Showing results (81-90 of 991) with videos related to

Sort By:
Pageof 100
Assay and Drug Development Technologies|May 12, 2012
Ion channel pharmacology under flow: automation via well-plate microfluidicsC Ian Spencer, Nianzhen Li, Qin Chen, et al.
Assay and Drug Development Technologies|December 29, 2009
Microbead arrays for the analysis of ErbB receptor tyrosine kinase activation and dimerization in breast cancer cellsImran H Khan, Jing Zhao, Paramita Ghosh, et al.
Assay and Drug Development Technologies|November 25, 2005
Drug discovery in the kinase inhibitory field using the Nested Chemical Library technologyGyörgy Kéri, Zsolt Székelyhidi, Péter Bánhegyi, et al.
Assay and Drug Development Technologies|November 18, 2017
A Functional Kinase Short Interfering Ribonucleic Acid Screen Using Protease-Activated Receptor 2-Dependent Opening of Transient Receptor Potential Vanilloid-4William G Darby, Megan S Grace, Kaylene J Simpson, et al.
Assay and Drug Development Technologies|January 10, 2019
Repositioning Tacrolimus: Evaluation of the Effect of Short-Term Tacrolimus Treatment on Osteoprogenitor Cells and Primary Cells for Bone Regenerative EngineeringEdward O'Neill, Komal Rajpura, Erica J Carbone, et al.
Assay and Drug Development Technologies|December 22, 2017
FLECS Technology for High-Throughput Single-Cell Force Biology and ScreeningIvan Pushkarsky
Assay and Drug Development Technologies|December 18, 2019
Phytochemical Repurposing of Natural Molecule: Sabinene for Identification of Novel Therapeutic Benefits Using In Silico and In Vitro ApproachesShamini Sharma, Jeena Gupta, Pranav Kumar Prabhakar, et al.
Assay and Drug Development Technologies|June 22, 2016
A Macrophage Infection Model to Predict Drug Efficacy Against Mycobacterium TuberculosisKaitlyn Schaaf, Virginia Hayley, Alexander Speer, et al.
Assay and Drug Development Technologies|July 28, 2021
AXTEX-4D: A Three-Dimensional Ex Vivo Platform for Preclinical Investigations of Immunotherapy AgentsAmbica Baru, Swati Sharma, Biswa Pratim Das Purakayastha, et al.
Assay and Drug Development Technologies|March 28, 2017
Using Chemoinformatics, Bioinformatics, and Bioassay to Predict and Explain the Antibacterial Activity of Nonantibiotic Food and Drug Administration DrugsNour Aldin Kahlous, Muhammad Al Mohdi Bawarish, Muhammad Arabi Sarhan, et al.
Pageof 100